O'Cearbhaill, R. E., Moroney, J. W., Martin, L. P., Tseng, J., Nieuwenhuysen, E. V., Bouberhan, S., Winer, I. S., Hays, J. L., Banda, K., Roque, D. R., Moreno, V., Song, M., Barretina-Ginesta, M., Manso, L., Yoo, S., Tabrizian, T., Peterman, M. J., Uldrick, T. S., Huang, G. S., Miller, E. (2026). A phase 1/2 study of REGN5668, a MUC16×CD28 costimulatory bispecific antibody, in combination with other targeted therapies, in patients with recurrent ovarian or endometrial cancer: Trial in progress update.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps5639